The interaction between nonalcoholic steatosis, anthropometric indicators and disturbance of lipid peroxidation and antioxidant defense in patients with signs of obesity.

Authors

  • A. Yu. Filippova

DOI:

https://doi.org/10.26641/2307-0404.2016.4.90792

Keywords:

nonalcoholic steatosis, obesity, body mass index, lipid peroxidation, antioxidant protection

Abstract

Aim - to study charac­teristics of indicators of lipid peroxidation (LPO) and antioxidant system (AOS), depending on the body mass index (BMI) in patients with non-alcoholic steatosis (NASP) in combination with obesity (OB) and pathology of the biliary tract (BT). The study involved 100 patients with NASP in combination with OB and BT pathology, who at the time of sonographic and morphological study of liver biopsy presented signs of hepatic steatosis. Among the patients there were 19 men and 81 women. The average age of patients - (53,67 ± 1,11) years. The control group consisted of 20 practically healthy persons (PHP). BMI is determined by the formula Quetelet. Depending on the degree of BMI increase all patients with NASH and obe­sity were divided into three groups: 1 group – with BМI 25-29,9 kg/m2 – ex­cessive body mass; 2 group – with BMI 30-34,9 kg/m2 – obesity of I degree; 3 group – with BMI 35–39,9 kg/m2 – obesity of ІІ degree. Status of LPO system was assessed by the concentration of malondialdehyde in plasma and red blood cells and the content of lipid peroxidation intermediates in the two phases of the lipid extract – isolated double bonds, diene conjugates, oksidien conjugates and the final LPO products – schiff bases. Factors of antioxidant defense activity were assessed by ceruloplasmin (CP), superoxide dismutase (SOD) and catalase in erythrocyte hemolysate. All LPO indicators have been activated in the two phases of lipid extract (from p<0,05 to p<0,001 when compared with a group of PHP and p<0,05 as compared to other groups of patients) and depended on increasing BMI. Indicators of AOS – SOD and catalase in all NASP groups practically did not differ from PHP parameters and did not depend on the increase of BMI. From the CP side a compensatory increase in its activity in response to the intensification of LPO was revealed. In NASP patients in combination with OB and comorbid disorders of BT the course of the disease was associated with significant violations of the oxidant-antioxidant balance, which depended on increasing BMI parameters.

Author Biography

A. Yu. Filippova

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of Internal Medicine 2
Dzerzhinsky str., 9, Dnipro, 49044, Ukraine

References

Kamyishnikov VS. [Clinical and laboratory diag-nosis of liver diseases]. Moscow: MEDpress-inform 2-e izd; 2014. Russian.

Leschine OA, Skvortsov VV. [Clinical-diagnostic value of serum ceruloplasmin in patients with chronic hepatitis B and C]. Poliklinika. Special Laboratory LPU.2012;29-30. Russian.

Lelukhina OV, Domashneva NA, Averyanova LP. [Comparative characteristics of penetration of erythrocyte membranes, status of lipid peroxidation and antioxidant protection in patients with hepatic steatosis combined with diseases of the biliary tract]. Gastro-enterology. Dnepropetrovsk. 2007;39:73-80. Ukrainian.

[Order of HM from Ukraine 13.06.2005 N 271. On approval of the protocols of medical care to patients in Gastroenterology]. Ukrainian.

Volchegorskiy IA, Nalimov FG, Yavoryanskiy BG. [Comparison of various approaches to the definition of peroxidation products in heptane-isopropanol extracts of blood]. Questions of medical chemistry.1989;127-30. Russian.

Filippova AYu. [The process of lipid peroxidation and status of antioxidant defense system in patients with nonalcoholic fatty liver disease]. Vrachebnoe delo. 2013;7:36-43. Ukrainian.

Novakovic T, Mekic M, Smilic L. Anthropo¬metric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods. Med Arch. 2014;68(1):22-6.

Hernaez R, Lazo M, Bonekamp S. Diagnostic accuracy and reliability of ultrasonography for the de-tection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082-90.

Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol. 2014;28(4):637-53.

Filippova Aleksandra. Non-alcoholic and alco-holic fatty liver disease in patients suffering from biliary tract pathology and obesity: clinical and functional aspects. Modern Science Moderni Vĕda. 2015;4:134-49.

Toouli James, Fried Michael, Ghafoor Khan Aamir. Obesity World Gastroenterology Organisation Global Guideline. 2009:1-30. Available from: http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/22_obesity.pdf.

Downloads

How to Cite

1.
Filippova AY. The interaction between nonalcoholic steatosis, anthropometric indicators and disturbance of lipid peroxidation and antioxidant defense in patients with signs of obesity. Med. perspekt. [Internet]. 2017Jan.11 [cited 2024Nov.13];21(4):54-62. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/90792

Issue

Section

CLINICAL MEDICINE